Navigation Links
Stem Cell Therapy Cures Type 1 Diabetes in Mice
Date:6/5/2013

By Serena Gordon
HealthDay Reporter

WEDNESDAY, June 5 (HealthDay News) -- Using an immune-suppressing medication and adult stem cells from healthy donors, researchers say they were able to cure type 1 diabetes in mice.

"This is a whole new concept," said the study's senior author, Habib Zaghouani, a professor of microbiology and immunology, child health and neurology at the University of Missouri School of Medicine in Columbia, Mo.

In the midst of their laboratory research, something unanticipated occurred. The researchers expected that the adult stem cells would turn into functioning beta cells (cells that produce insulin). Instead, the stem cells turned into endothelial cells that generated the development of new blood vessels to supply existing beta cells with the nourishment they needed to regenerate and thrive.

"I believe that beta cells are important, but for curing this disease, we have to restore the [blood vessels]," Zaghouani said.

It's much too early to know if this novel combination would work in humans. But the findings could stimulate new avenues of research, another expert says.

"This is a theme we've seen a few times recently. Beta cells are plastic and can respond and expand when the environment is right," said Andrew Rakeman, a senior scientist in beta cell regeneration at the Juvenile Diabetes Research Foundation (JDRF). "But, there's some work still to be done. How do we get from this biological mechanism to a more conventional therapy?"

Results of the study were published online May 28 in Diabetes.

The exact cause of type 1 diabetes, a chronic disease sometimes called juvenile diabetes, remains unclear. It's thought to be an autoimmune disease in which the body's immune system mistakenly attacks and damages insulin-producing beta cells (found in islet cells in the pancreas) to the point where they no longer produce insulin, or they produce very little insulin. Insulin is a hormone necessary to convert the carbohydrates from food into fuel for the body and brain.

Zaghouani said he thinks the beta cell's blood vessels may just be collateral damage during the initial autoimmune attack.

To avoid dire health consequences, people with type 1 diabetes must take insulin injections multiple times a day or obtain continuous infusions through an insulin pump. It's estimated that 3 million U.S. children and adults have the disease, which increased by almost one-quarter in Americans under age 20 between 2001 and 2009.

Zaghouani and his colleagues previously tested a drug called Ig-GAD2 that would destroy the immune system cells responsible for destroying the beta cells. The drug worked well to prevent type 1 diabetes, but it didn't work as a therapy when type 1 diabetes was more advanced.

"This made us question whether there were enough beta cells left when the disease is advanced," said Zaghouani. After conducting bone marrow transplants, the researchers came to a surprising conclusion. "The bone marrow cells did go to the pancreas, but they didn't become beta cells; they became endothelial cells," he said. "So, the problem wasn't a lack of beta cells or their precursor, the problem was that the blood vessels that irrigate the islet cells are damaged. That was a very novel and intriguing finding."

The immune-suppressing drug was given for 10 weeks, and bone marrow transplants were given intravenously on weeks 2, 3 and 4 after the diabetes diagnosis.

The mice were cured throughout the study follow-up of 120 days, which is about the lifespan of a mouse, Zaghouani said.

Zaghouani said he believes the immune attack may not be ongoing, and he hopes to give the mice bone marrow transplants without the immune-suppressing drug to see if that is sufficient to cure their disease.

Rakeman explained that while current thinking is that "a cure would need to address the immune system attack and the regrowth of beta cells," some scientists suspect that the immune system might not have initially gone after healthy beta cells. It's possible that the immune system actually targeted beta cells that had already been damaged. "This is a different way of thinking how the disease develops," said Rakeman.

Rakeman said this research might spur the development of new drug targets that could mimic the action of the stem cells. But the current research is many steps away from such a therapy for humans, according to both experts.

More information

Learn more about type 1 diabetes from the U.S. National Library of Medicine.

SOURCES: Habib Zaghouani, Ph.D., professor, microbiology and immunology, child health and neurology, and the J. Lavenia Edwards Chair in Pediatrics, University of Missouri School of Medicine, Columbia, Mo.; Andrew Rakeman, Ph.D., senior scientist, beta cell regeneration, JDRF (Juvenile Diabetes Research Foundation); May 28, 2013 Diabetes, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. EORTC study shows radiotherapy and surgery provide regional control for breast cancer patients
2. South Bay Vascular Center and Vein Institute Educates Public About Sclerotherapy
3. Additional Data Released at ASCO Annual Meeting Shows More Promising Results for Immunotherapy as a Treatment Option in Melanoma
4. Melanoma Patients Receive Promising News Regarding Cancer Immunotherapy Combination Treatment
5. Therapy that heats and destroys bone tumors eases patients pain
6. MGH-led studies shed new light on targeted lung cancer therapy
7. Ayurveda Training in Marma Therapy, Basti, Abhyanga Massage, Swedana, and Ayurvedic Facial Offered in 2013 by the Leading Ayurvedic School in the United States
8. North American Seminars Introduces Responsible CME, a Program That Combined Live Physical Therapy Continuing Education with Online Continuing Education Courses
9. Mainz University obtains new CRC Nanodimensional polymer therapeutics for tumor therapy
10. New therapy is tolerable in lung cancer
11. Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Sixth Annual One Day Sale on Gift Certificates Will Take Place on June 19, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stem Cell Therapy Cures Type 1 Diabetes in Mice
(Date:2/12/2016)... , ... February 12, 2016 , ... Every winter, someone ... This winter the West Penn Burn Center, part of the Allegheny Health ... to bring you the “Space Heaters Need Space” campaign. , “Space ...
(Date:2/12/2016)... ... 12, 2016 , ... AssureVest Insurance Group, a locally owned insurance firm with ... will raise funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and ... is in a low-income area and has more than 60 2nd and 3rd graders ...
(Date:2/12/2016)... ... ... Vail knee specialist Robert LaPrade, MD, PhD was named one ... consists of physicians establishing, leading and partnering with ambulatory surgery centers across the United ... Center, also known as an ASC, is a modern health care facility focused on ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young Asset Protection, a full ... of the latest charity campaign in their community enrichment program. Art Expression utilizes ... worthy cause are currently being accepted at: http://artexpressioninc.org/ . , Art Expression ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Miami Dental ... implants to their Miami dental office. Beginning in January, Miami Dental Specialists will ... Miami Dental Specialists are the first office to be chosen by the dental implant ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12 2016  OMS Supply, a large ... medical practitioners, announced today the recent launching of their ... a variety of features that enhance the user experience ... supplies. --> --> ... fairly new company that started in early 2016, they ...
(Date:2/12/2016)... Maharashtra, February 12, 2016 ... report titled Chronic Inflammation Global Clinical Trials Review, ... of the global clinical trials landscape along with ... by Region, Country (G7 & E7), Trial Status, ... and reviews top companies involved and enlists all ...
(Date:2/11/2016)... IRVINE, Calif., Feb. 11, 2016 PRO-DEX, INC. (NasdaqCM: ... quarter ended December 31, 2015. The Company also filed its ... fiscal year 2016 with the Securities and Exchange Commission today. ... December 31, 2015 --> --> ... 2015 increased $2.6 million, or 95%, to $5.4 million from ...
Breaking Medicine Technology: